FHA
DYN icon

First Horizon Advisors’s Dyne Therapeutics DYN Stock Holding History

First Horizon Advisors’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$3.53K Buy
371
+237
+177% +$2.61K ﹤0.01% 1917
2025
Q1 		$1.4K Sell
134
-22
-14% -$315 ﹤0.01% 2069
2024
Q4 		$3.68K Sell
156
-23
-13% -$680 ﹤0.01% 1872
2024
Q3 		$6.43K Buy
179
+26
+17% +$1.03K ﹤0.01% 1744
2024
Q2 		$5.4K Buy
+153
New +$4.45K ﹤0.01% 1737

Other funds holding DYN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Horizon Advisors's DYN Position: Q2 2025 in Review

First Horizon Advisors increased its Dyne Therapeutics (DYN) stake by 177% in Q2 2025, buying an estimated $2.61K and bringing the position to 371 shares worth $3.53K. The position accounts for ﹤0.01% of the portfolio, ranked #1917.

First Horizon Advisors first reported a position in DYN in Q2 2024 and has held it in 5 quarters since. The position peaked at $6.43K in Q3 2024. 197 funds tracked by Wall St. Rank hold DYN as of Q2 2025.

  • First Horizon Advisors held 371 shares of Dyne Therapeutics worth $3.53K as of Q2 2025.
  • First Horizon Advisors bought 237 Dyne Therapeutics shares in Q2 2025, an estimated $2.61K.
  • Dyne Therapeutics made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1917 holding.
  • First Horizon Advisors first reported a position in Dyne Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • First Horizon Advisors's Dyne Therapeutics position peaked at $6.43K in Q3 2024.
  • 197 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.